The Director, Market Access is responsible for defining and executing the market access, pricing, and reimbursement strategy for Corcept’s oncology portfolio in DACH. This role is critical to ensuring timely, sustainable, and compliant patient access through successful navigation of DACH complex access environment, including AMNOG, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Bundesausschuss (G‑BA), Statutory Health Insurance (SHI) negotiations, and regional access dynamics. 

The Director will report to DACH GM and serve as the market access lead for DACH, partnering closely with U.S. Headquarters Market Access, Health Economics and Outcomes Research (HEOR), Medical, Commercial and Legal and Compliance to drive optimal launch readiness, reimbursement outcomes, and long‑term access success. 

Responsibilities:

Market Access Strategy & Leadership 

• Develop and lead the DACH German market access strategy for Corcept’s oncology assets across the product lifecycle, from early pipeline through launch and post‑launch optimization
• Serve as the primary market access subject matter expert for DACH, advising senior leadership on access risks, opportunities, and strategic trade‑offs
• Ensure alignment between U.S. access strategy and local execution, providing clear input into German pricing, value, and evidence planning
• Collaborate with DACH commercial teams including marketing, sales, and medical

 Pricing, Reimbursement & AMNOG Execution 

• Lead DACH‑specific pricing and reimbursement strategy, including launch price positioning and lifecycle price management
• Own and drive the AMNOG process, including: 
• Strategic input into dossier development 
• Engagement planning for IQWiG and G‑BA assessments 
• Preparation for SHI price negotiations and arbitration scenarios 
• Partner with U.S. teams to translate clinical and economic value into compelling, compliant value propositions for German payers
• Coordination with Medical, HEOR/RWE, Clinical development, and Regulatory on evidence strategy that reflects both national and regional payer expectations

Stakeholder & Payer Engagement 

• Lead strategic engagement planning with national and regional payers, sickness funds, and key decision‑making bodies
• Provide guidance and support for compliant payer communication strategies, in collaboration with HEOR/RWE, Legal and Compliance and Medical colleagues
• Monitor and assess evolving policy, regulatory, and reimbursement landscapes in Germany and proactively adapt access strategy

Cross‑Functional Leadership 

• Act as a core member of the Germany Leadership Team, partnering with U.S. Market Access. Commercial, Medical, Regulatory, and other relevant functions
• Ensure market access considerations are embedded early in launch planning, forecasting, and business planning
• Contribute to regional and European access forums, sharing insights and best practices
• Uphold Corcept’s ethics and patient‑first principles by embedding collaboration, evidence‑based decision‑making, and accountable leadership into all aspects of strategy and execution

Preferred Skills, Qualifications and Technical Proficiencies:

• Fluency in German and English required 
• Extensive experience in pharmaceutical market access in Germany, with deep expertise in AMNOG, G‑BA, IQWiG, and SHI pricing negotiations. Experience in other EU markets is a plus
• Demonstrated success leading market access strategy for specialty and/or oncology products
• Strong strategic mindset with the ability to operate at both detail and executive levels
• Proven ability to lead complex, cross‑functional initiatives in a highly regulated environment
• Excellent communication and influencing skills, with credibility engaging senior internal and external stakeholders
• Demonstrated ability to develop strategy and the ability to execute compliantly
• Moderate travel required, primarily within Germany, with occasional travel to regional or U.S. headquarters and key external meetings

Preferred Education and Experience:

• Bachelor’s degree required; advanced degree (e.g., Master’s, PhD, MBA) preferred
• Relevant training or certifications in health economics, market access, or health policy preferred
• Eight to 10+ years of total professional experience with 5+ years in progressively senior or leadership roles 

#LI-Remote

We are seeking a Key Account Manager (KAM) – Oncology to support the launch and growth of Corcept’s oncology portfolio in Germany. This is a unique opportunity to join a pioneering organization as it expands its oncology presence in the European market. The Key Account Manager is responsible for driving awareness, adoption, and appropriate use of Corcept’s oncology products within assigned key accounts across Germany. The role focuses on strategic account management, stakeholder engagement, and compliant promotional activities to ensure optimal patient access in a complex healthcare environment.

Key Responsibilities:

• Develop and execute account based strategic plans tailored to the needs of oncologists, multidisciplinary care teams, hospital systems, and other relevant stakeholders
• Achieve sales and performance objectives through high-quality, compliant interactions with healthcare professionals and key decision makers within oncology accounts
• Provide accurate, balanced, and compliant information on product clinical data, safety profile, and appropriate patient selection
• Collaborate closely with cross functional partners including Medical Affairs, Market Access, Marketing, and Commercial Operations to optimize account outcomes to ensure coordinated engagement with key accounts
• Analyze local market dynamics, competitive landscape, treatment pathways, and access barriers to identify opportunities and risks
• Ensure all activities are conducted in strict compliance with German pharmaceutical law, industry codes, and Corcept standards
• Represent Corcept professionally at national and regional oncology congresses and scientific meetings in Germany
• Contribute to a high performing, values driven culture through accountability, integrity, continuous development, and a patient first mindset

Preferred Skills, Qualifications and Technical Proficiencies:

• Fluency in English (written and spoken) is required, including the ability to communicate effectively with colleagues in other geographies
• Strong understanding of German oncology treatment guidelines, reimbursement mechanisms, and healthcare system dynamics
• Demonstrated ability to develop and execute strategic account plans in a competitive environment
• High level of business acumen, analytical capability, and cross functional collaboration
• Willingness to travel extensively within the assigned territory (approximately 50–75%)

Preferred Education and Experience:

• Bachelor’s degree in Life Sciences, Business, or a related field
• Minimum 10 years of pharmaceutical sales experience, including at least 5 years in oncology
• Proven success managing complex hospital and specialist oncology accounts in Germany
• Oncology product launch experience in Germany
• Experience in gynecologic oncology, ovarian cancer, or related oncology subspecialties
• Background in startup or growth stage pharmaceutical organizations
• Established relationships with oncologists, cancer centers, and key opinion leaders within Germany

Legal & Professional Certifications (Germany):

To perform this role in Germany, candidates must meet the legal requirements for pharmaceutical field representatives, including:

• Certification as a Pharmaceutical Sales Representative (Pharmareferent/in) in accordance with §75 of the German Medicines Act (Arzneimittelgesetz, AMG)
  • A recognized degree in pharmacy, medicine, chemistry, biology, or a related life‑science discipline or
  • Successful completion of the IHK Pharmareferent (IHK) certification or an equivalent recognized qualification
• This may be fulfilled through:
• Demonstrated knowledge of:
• German pharmaceutical law (AMG)
• HWG (Heilmittelwerbegesetz – German Drug Advertising Act)
• Industry codes (e.g., FSA Code of Conduct)

 _#LI-Remote